ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,60%(-0,016) 1D
20-ноя., 11:02:04 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
344,28 млн
Avg. vol.
785,30 миң
Volume
161,55 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
344,28 млн
Avg. vol.
785,30 миң
Volume
161,55 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
The Motley Fool
·
48 мүнөт мурун
Bitcoin Is 35% Below Its 52-Week High While the S&P 500 Is Up. Here’s What That Says About the Digital Gold Thesis.
MarketWatch
·
25 мүнөт мурун
Here’s what happened next after previous times the S&P 500 losing streak reached six sessions
Benzinga
·
24 мүнөт мурун
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Weighs Iran Decision— INTU, ROST, KEYS in Focus
MarketForces Africa
·
2 саат мурун
S&P 500, Nasdaq, Dow Jones Dip Amidst Anthropic IPO Debut
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com